The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Ultragenyx Pharmaceutical Inc. shares valued at $574,644 were sold by Kassberg Thomas Richard on Mar 11 ’24. At $49.93 per share, Kassberg Thomas Richard sold 11,509 shares. The insider’s holdings dropped to 252,823 shares worth approximately $11.15 million following the completion of this transaction.
Also, Fust Matthew K sold 12,195 shares, netting a total of over 620,443 in proceeds. Following the sale of shares at $50.88 each, the insider now holds 14,860 shares.
Before that, Harris Erik had sold 4,768 shares from its account. In a trade valued at $256,328, the EVP & Chief Commercial Officer traded Ultragenyx Pharmaceutical Inc. shares for $53.76 each. Upon closing the transaction, the insider’s holdings decreased to 4,768 shares, worth approximately $2.96 million.
As published in their initiating research note from Wells Fargo on December 08, 2023, Ultragenyx Pharmaceutical Inc. [RARE] has been an Overweight and the price target has been revised to $72. As of June 06, 2023, Evercore ISI has increased its “an In-line” rating to a “an Outperform” for RARE. Earlier on April 26, 2023, Cantor Fitzgerald initiated its rating. Their recommendation was “an Overweight” for RARE stock.
Analyzing RARE Stock Performance
During the last five days, there has been a drop of approximately -14.53%. Over the course of the year, Ultragenyx Pharmaceutical Inc. shares have dropped approximately -7.76%. Shares of the company reached a 52-week high of $54.56 on 03/01/24 and a 52-week low of $41.87 on 01/18/24. A 50-day SMA is recorded $48.04, while a 200-day SMA reached $42.17. Nevertheless, trading volume fell to 0.89 million shares from 0.89 million shares the previous day.
Support And Resistance Levels for Ultragenyx Pharmaceutical Inc. (RARE)
According to the 24-hour chart, there is a support level at 42.70, which, if violated, would cause prices to drop to 41.28. In the upper region, resistance lies at 45.08. The next price resistance is at 46.04. RSI (Relative Strength Index) is 39.92 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -4.33, which suggests the price will decrease in the coming days. Percent R is at 80.09%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
